HKSE - Delayed Quote HKD

OCUMENSION-B (1477.HK)

6.830
+0.780
+(12.89%)
At close: 4:08:38 PM GMT+8
Advanced Chart
Loading Chart for 1477.HK
  • Previous Close 6.050
  • Open 6.050
  • Bid 6.790 x --
  • Ask 6.800 x --
  • Day's Range 5.960 - 6.900
  • 52 Week Range 3.620 - 7.410
  • Volume 17,431,270
  • Avg. Volume 3,559,019
  • Market Cap (intraday) 5.486B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.420
  • Earnings Date Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.34

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. Its portfolio includes products and drugs for the treatment of chronic non-infectious uveitis, infective and allergic conjunctivitis, diabetic macular edema, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. The company was founded in 2017 and is based in Suzhou, the People's Republic of China.

www.ocumension.com

489

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about OCUMENSION-B

Recent News: 1477.HK

View More
View More

Performance Overview: 1477.HK

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1477.HK
52.46%
HANG SENG INDEX (^HSI)
18.05%

1-Year Return

1477.HK
0.44%
HANG SENG INDEX (^HSI)
20.60%

3-Year Return

1477.HK
36.52%
HANG SENG INDEX (^HSI)
14.31%

5-Year Return

1477.HK
84.12%
HANG SENG INDEX (^HSI)
2.94%

Compare To: 1477.HK

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

1477.HK
OCUMENSION-B
6.830
+12.89%
Mkt Cap HKD 5.486B
Industry Biotechnology
1541.HK
IMMUNEONCO-B
7.510
+8.53%
Mkt Cap HKD 3.059B
Industry Biotechnology
2696.HK
Shanghai Henlius Biotech, Inc.
40.550
+3.18%
Mkt Cap HKD 22.039B
Industry Biotechnology
2256.HK
Abbisko Cayman Limited
8.660
+5.10%
Mkt Cap HKD 5.746B
Industry Biotechnology
2509.HK
Qyuns Therapeutics Co., Ltd.
11.560
+3.03%
Mkt Cap HKD 2.567B
Industry Biotechnology
2171.HK
CARsgen Therapeutics Holdings Limited
20.800
+5.69%
Mkt Cap HKD 11.428B
Industry Biotechnology
3759.HK
Pharmaron Beijing Co., Ltd.
13.380
+1.21%
Mkt Cap HKD 40.335B
Industry Biotechnology
1952.HK
Everest Medicines Limited
44.300
-5.44%
Mkt Cap HKD 14.369B
Industry Biotechnology
6990.HK
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
336.000
+1.51%
Mkt Cap HKD 76.362B
Industry Biotechnology
2157.HK
Lepu Biopharma Co., Ltd.
4.410
+1.15%
Mkt Cap HKD 7.544B
Industry Biotechnology
6855.HK
Ascentage Pharma Group International
44.250
-3.49%
Mkt Cap HKD 15.411B
Industry Biotechnology

Statistics: 1477.HK

View More

Valuation Measures

Annual
As of 5/19/2025

  • Market Cap

    4.86B

  • Enterprise Value

    4.05B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.15

  • Price/Book (mrq)

    1.19

  • Enterprise Value/Revenue

    8.96

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -64.29%

  • Return on Assets (ttm)

    -5.29%

  • Return on Equity (ttm)

    -8.02%

  • Revenue (ttm)

    417.31M

  • Net Income Avi to Common (ttm)

    -268.27M

  • Diluted EPS (ttm)

    -0.420

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    769.2M

  • Total Debt/Equity (mrq)

    0.68%

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: 1477.HK

View More
View More

Company Insights: 1477.HK

Research Reports: 1477.HK

View More
View More

People Also Watch

9997.HK Kangji Medical Holdings Limited
8.000
+2.56%
 
9996.HK Peijia Medical Limited
5.760
+6.67%
 
1952.HK Everest Medicines Limited
44.300
-5.44%
 
6078.HK Hygeia Healthcare Holdings Co., Limited
15.200
+2.01%
 
6978.HK Immunotech Biopharm Ltd
3.360
-4.82%
 
9969.HK InnoCare Pharma Limited
10.600
+3.92%
 
1521.HK FRONTAGE
1.120
+0.90%
 
9966.HK Alphamab Oncology
7.610
+7.18%
 
2616.HK CStone Pharmaceuticals
3.400
+15.65%
 
9926.HK Akeso, Inc.
82.400
-1.38%
 
3347.HK Hangzhou Tigermed Consulting Co., Ltd
26.700
+4.91%
 
9939.HK Kintor Pharmaceutical Limited
1.280
+4.07%
 
1877.HK JUNSHI BIO
15.680
+2.75%
 
6855.HK Ascentage Pharma Group International
44.250
-3.49%
 
1501.HK INT MEDICAL
26.000
-1.33%
 
1873.HK VIVA BIOTECH
1.750
-1.13%